Barclays’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,018
| Closed | -$1K | – | 4770 |
|
|
2022
Q3 | $1K | Hold |
3,018
| – | – | ﹤0.01% | 4607 |
|
|
2022
Q2 | $1K | Sell |
3,018
-5,525
| -65% | -$1.83K | ﹤0.01% | 4668 |
|
|
2022
Q1 | $6K | Sell |
8,543
-6,313
| -42% | -$4.43K | ﹤0.01% | 4573 |
|
|
2021
Q4 | $34K | Sell |
14,856
-2,561
| -15% | -$5.86K | ﹤0.01% | 3065 |
|
|
2021
Q3 | $80K | Sell |
17,417
-1,593
| -8% | -$7.32K | ﹤0.01% | 3290 |
|
|
2021
Q2 | $84K | Sell |
19,010
-9,557
| -33% | -$42.2K | ﹤0.01% | 3199 |
|
|
2021
Q1 | $208K | Buy |
28,567
+8,417
| +42% | +$61.3K | ﹤0.01% | 3109 |
|
|
2020
Q4 | $154K | Buy |
20,150
+11,656
| +137% | +$89.1K | ﹤0.01% | 2818 |
|
|
2020
Q3 | $77K | Buy |
8,494
+1,888
| +29% | +$17.1K | ﹤0.01% | 3121 |
|
|
2020
Q2 | $56K | Buy |
6,606
+3,877
| +142% | +$32.9K | ﹤0.01% | 3365 |
|
|
2020
Q1 | $14K | Sell |
2,729
-5,573
| -67% | -$28.6K | ﹤0.01% | 3439 |
|
|
2019
Q4 | $60K | Buy |
8,302
+4,254
| +105% | +$30.7K | ﹤0.01% | 3558 |
|
|
2019
Q3 | $44K | Sell |
4,048
-1,343
| -25% | -$14.6K | ﹤0.01% | 3716 |
|
|
2019
Q2 | $70K | Buy |
5,391
+3,176
| +143% | +$41.2K | ﹤0.01% | 3739 |
|
|
2019
Q1 | $22K | Buy |
2,215
+217
| +11% | +$2.16K | ﹤0.01% | 3898 |
|
|
2018
Q4 | $21K | Buy |
+1,998
| New | +$21K | ﹤0.01% | 3376 |
|